Supplements

Rare Rheumatologic Diseases Special Report 2019


 

The Rare Rheumatologic Diseases Special Report is a supplement to Rheumatology News, providing readers with information about how registries for rare pediatric diseases such as polyarticular juvenile idiopathic arthritis, scleroderma, and myositis, have led to important insights into treatments and disease characteristics. The issue also discusses updated recommendations on the management of large-vessel vasculitis from the European League Against Rheumatism and recent efforts to establish classification criteria for chronic nonbacterial osteomyelitis/chronic recurrent multifocal osteomyelitis.

Click here to read the special report.

Recommended Reading

CMS has plan if ACA overturned in court; Verma silent on details
MDedge Rheumatology
Many children who present to headache clinics have joint hypermobility
MDedge Rheumatology
Serlopitant improves psoriatic itch in phase 2 study
MDedge Rheumatology
Demeaning patient behavior takes emotional toll on physicians
MDedge Rheumatology
CBD: What physicians need to know about it
MDedge Rheumatology
PASI-75 with ixekizumab approaches 90% in pediatric psoriasis study
MDedge Rheumatology
TNF level–based dosing of infliximab does not increase RA remission rate
MDedge Rheumatology
Severe hypoglycemia, poor glycemic control fuels fracture risk in older diabetic patients
MDedge Rheumatology
‘Time lost is brain lost’
MDedge Rheumatology
No infection increase seen with biologics in older psoriasis patients
MDedge Rheumatology